<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(1)</volume><submitter>Li XY</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>The self-reported quality of life (QoL) should be carefully listened to in progressive supranuclear palsy (PSP) from the patient-centered perspective. However, there was still a lack of short QoL measurement tool in atypical parkinsonism.&lt;h4>Objective&lt;/h4>We aimed to test whether the short Parkinson's Disease Questionnaire-8 (PDQ-8) was effective in assessing QoL in PSP, comparing with Progressive Supranuclear Palsy Quality of Life Scale (PSP-QoL) and Parkinson's Disease Questionnaire-39 (PDQ-39).&lt;h4>Methods&lt;/h4>132 patients with clinical diagnosed PSP, including PSP-Richardson syndrome (RS) subtype (n = 71) and PSP-non-RS subtype (n = 61) were recruited for clinical evaluation including QoL assessment. The detailed QoL profiles and possibility of using PDQ-8 were system</pubmed_abstract><journal>Journal of Parkinson's disease</journal><pagination>83-91</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9912724</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>PDQ-8: A Simplified and Effective Tool Measuring Life Quality in Progressive Supranuclear Palsy.</pubmed_title><pmcid>PMC9912724</pmcid><pubmed_authors>Li G</pubmed_authors><pubmed_authors>Wu B</pubmed_authors><pubmed_authors>Shen B</pubmed_authors><pubmed_authors>Sun YM</pubmed_authors><pubmed_authors>Wang J</pubmed_authors><pubmed_authors>Liang XN</pubmed_authors><pubmed_authors>Chen MJ</pubmed_authors><pubmed_authors>Yao RX</pubmed_authors><pubmed_authors>Progressive Supranuclear Palsy Neuroimage Initiative (PSPNI)</pubmed_authors><pubmed_authors>Li XY</pubmed_authors><pubmed_authors>Liu FT</pubmed_authors><pubmed_authors>Wu JJ</pubmed_authors><pubmed_authors>Yang YJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>PDQ-8: A Simplified and Effective Tool Measuring Life Quality in Progressive Supranuclear Palsy.</name><description>&lt;h4>Background&lt;/h4>The self-reported quality of life (QoL) should be carefully listened to in progressive supranuclear palsy (PSP) from the patient-centered perspective. However, there was still a lack of short QoL measurement tool in atypical parkinsonism.&lt;h4>Objective&lt;/h4>We aimed to test whether the short Parkinson's Disease Questionnaire-8 (PDQ-8) was effective in assessing QoL in PSP, comparing with Progressive Supranuclear Palsy Quality of Life Scale (PSP-QoL) and Parkinson's Disease Questionnaire-39 (PDQ-39).&lt;h4>Methods&lt;/h4>132 patients with clinical diagnosed PSP, including PSP-Richardson syndrome (RS) subtype (n = 71) and PSP-non-RS subtype (n = 61) were recruited for clinical evaluation including QoL assessment. The detailed QoL profiles and possibility of using PDQ-8 were system</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023</publication><modification>2025-04-18T15:52:21.696Z</modification><creation>2025-04-07T02:45:08.933Z</creation></dates><accession>S-EPMC9912724</accession><cross_references><pubmed>36591660</pubmed><doi>10.3233/JPD-223553</doi></cross_references></HashMap>